Patents Assigned to CBT Development Limited
  • Publication number: 20130125434
    Abstract: A display apparatus for a vehicle including a vent portion (1) comprising a through-opening defining an air intake mouth, and attachment means adapted to render the vent portion attachable therewith to a surface of the vehicle in a position intimately proximate thereto to permit the air-intake mouth to intake vehicle-displaced airflow at the aforesaid surface of the vehicle. A flexible sleeve portion (35) defines an air duct extending from the through-opening to an air outlet opening of the sleeve portion being inflatable by action of a flow of air therethrough from the through-opening to display an outer surface of the inflated sleeve portion.
    Type: Application
    Filed: May 17, 2011
    Publication date: May 23, 2013
    Applicant: CBT Developments Limited
    Inventor: Raymond Cozens
  • Patent number: 8252766
    Abstract: The compound spongosine (2-methoxyadenosine), of the class of adenosines, is useful as an analgesic, particularly in a method of preventing, treating, or ameliorating pain which comprises administering spongosine (2-methoxyadenosine) to a subject in need of such prevention, treatment, or amelioration.
    Type: Grant
    Filed: December 9, 2003
    Date of Patent: August 28, 2012
    Assignee: CBT Development Limited
    Inventor: Peter Richardson
  • Patent number: 7906518
    Abstract: The invention relates to a method of improving oral drug absorption of adenosine analogues by the use of 2?,3?-methylidene acetal adenosine pro-drugs and to the use of these pro-drugs as medicaments. The invention further relates to compounds that are pro-drugs of adenosine receptor agonists, and to their use as therapeutic compounds, in particular as analgesic or anti-inflammatory compounds, or as disease modifying antirheumatic drugs (DMARDs), and to methods of preventing, treating or ameliorating pain or inflammation using these compounds.
    Type: Grant
    Filed: June 26, 2007
    Date of Patent: March 15, 2011
    Assignee: CBT Development Limited
    Inventor: Edward D. Savory
  • Patent number: 7820811
    Abstract: The invention relates to a method of improving oral drug absorption of adenosine analogues by the use of 2?-methoxy adenosine pro-drugs and to the use of these pro-drugs as medicaments. The invention further relates to compounds that are pro-drugs of adenosine receptor agonists, and to their use as therapeutic compounds, in particular as analgesic or anti-inflammatory compounds, or as disease modifying antirheumatic drugs (DMARDs), and to methods of preventing, treating or ameliorating pain or inflammation using these compounds.
    Type: Grant
    Filed: June 26, 2007
    Date of Patent: October 26, 2010
    Assignee: CBT Development Limited
    Inventor: Edward D. Savory
  • Patent number: 7807685
    Abstract: Compounds of formula (I) below are disclosed. Their use as medicaments is described, in particular for the treatment of pain or inflammation: wherein: when X=Y=Z=OH, R1 is OCH2CF2CF3, phenoxy (substituted with 3-(4-trifluoromethylphenyl), 3,4-dichloro, (3-trifluoromethyl,4-fluoro), (3-trifluoromethyl,4-chloro), (3-chloro, 4-cyano), or 3,5-bis(trifluoromethyl)), 1-piperazinyl(4-(3,4-dichlorophenyl)), phenyl (substituted with 3,4-dichloro, 3,5-difluoro, 3,5-bis(trifluoromethyl) or 3,4,5-trifluoro) or 2-benzofuranyl; or when X=Y=OH and Z=OMe, R1 is OCH3, OCH2CHF2, OCH2cyclopentyl, O-(2,5-difluorophenyl) or (S)-sec-butylamino; or when X=H and Y=Z=OH, R1 is n-hexylamino or cyclopentylamino; or when (IV) X=Z=OH and Y=H, R1 is cyclopentylamino; or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 26, 2007
    Date of Patent: October 5, 2010
    Assignee: CBT Development Limited
    Inventors: Michael Higginbottom, Edward D. Savory, Giles A. Brown, Viet-Anh A. Horgan, Emma J. Chapman